FDA Overhauls Drug Risk Disclosures For Pregnant Women
The U.S. Food and Drug Administration on Wednesday finalized a major overhaul of how prescription drug labels disclose risks to women who are pregnant or breastfeeding, forcing drugmakers to revisit warnings...To view the full article, register now.
Already a subscriber? Click here to view full article